cannula for injection in blood vessels
microvascular eye tec - רופא - קנולה להחדרת תרופות לכלי דם דקים
intravascular system for hemodynamics pressure measurements in coronary vessels (native + vein grafts)
גאמידה בע"מ - רופא - היצרות בעורק הקורונרי כאשר יש ספק בצורך לטפל בה
רפמיון תמיסה
pfizer pharmaceuticals israel ltd - sirolimus - תמיסה (פומי) - sirolimus 1 mg/ml - sirolimus - sirolimus - rapamune is indicated for the prophylaxis of organ rejection in adult patients at low to moderate immunological risk receiving a renal transplant. it is recommended that rapamune be used initially in combination with cyclosporine microemulsion and corticosteroids for 2 to 3 months. rapamune may be continued as maintenance therapy with corticosteroids only if cyclosporine can be progressively discontinued.
צייטוטק 200 מקג טבליות
pfizer pfe pharmaceuticals israel ltd - misoprostol - טבליה - misoprostol 200 mcg - misoprostol - misoprostol - for the treatment of duodenal and gastric ulcer.treatment and prevention nsaid induced ulcers lesions, erosions, while nsaid therapy continues.use in conjunction with mifepristone subject to the approval of a committee for the termination of pregnancy according to the israeli penal law 1977.first-trimester pregnancy failure: use is intended for emptying the uterus in states of first trimester pregnancy failure, including: presentation of a pregnancy sac in the uterus with no fetal echo, missed abortion (until week 11+6 and a fetus 40 mm in length) or incomplete abortion. the preparation is to be used after location of the sac in the uterus has been proved and the diagnosis of pregnancy failure is certain. the preparation can be used for this purpose in an ambulatory setting. the dosage and route of administration will be similar to the use of cytotec in pregnancy termination after using mifegyne. informed consent and medical surveillance are required.softening and dilation of the cervix for performing intraut
aneugraftnx
itgi medical ltd - רופא - the aneugraftnx is specifically designed for intraluminal chronic placement where overlay of a cover on the vessel wall is required.
mguard prime
inspire md ltd - רופא - mguard prime coronary stent system is indicated for improving luminal diameter in vessels with reference diameter from 2.5 to 4.0 mm having lesion length <38 mm and providing embolic protection in the following cases: • symptomatic coronary artery disease due to discrete de novo or restenotic lesion in native coronary artery. • symptomatic coronary artery disease due to culprit lesion in saphenous vein graft • treatment of coronary lesion in patients undergoing primary or rescue pci for acute st-segment elevation myocardial infarction(stemi) • treatment of coronary lesion having atherothrombotic appearance in patients with non st-elevation acute coronary syndromes (unstable angina and non st-segment elevation myocardial infarction).
electro surgery system coblation
טי. סי. טכנוקר מוצרי בריאות בע"מ - רופא - ablation, resection and coagulation of soft tissue and hemostasis of blood vessels in otorhinolaryngology ent
surpass aneurysm-embolization system
surpass medical ltd. - רופא - the aneurysm-embolization system is indicated for use for the treatment of saccular, or fusiform intracranial aneurysms arising from a parent vessel with a diameter of ?2 mm and ?6 mm.
direct stent - stent graft
שילה חדשנות רפואית בע"מ - רופא - perforation or aneurism in vessels